We’re Keeping An Eye On CymaBay Therapeutics’s (NASDAQ:CBAY) Cash Burn Rate

 

We’re Keeping An Eye On CymaBay Therapeutics’s (NASDAQ:CBAY) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring …

More We’re Keeping An Eye On CymaBay Therapeutics’s (NASDAQ:CBAY) Cash Burn Rate Videos

Leave a Reply